[1] ZHAO Y F, MA X Q, WANG R, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome:the Systematic Investigation of Gastrointestinal Diseases in China (SILC)[J]. Alimentary Pharmacology & Therapeutics, 2011, 34(8):1020-1029.
[2] GUO M, YAO J, YANG F, et al. The composition of intestinal microbiota and its association with functional constipation of the elderly patients[J]. Future Microbiology, 2020, 15(3):163-175.
[3] WOJTYNIAK K, SZAJEWSKA H.Systematic review:probiotics for functional constipation in children[J]. European Journal of Pediatrics, 2017, 176(9):1155-1162.
[4] 中华医学会消化病学分会胃肠动力学组, 功能性胃肠病协作组.中国慢性便秘专家共识意见(2019, 广州)[J]. 中华消化杂志, 2019, 39(9):577-598.
[5] PANNEMANS J, MASUY I, TACK J.Functional constipation:individualising assessment and treatment[J]. Drugs, 2020, 80(10):947-963.
[6] JIN L, DENG L, WU W, et al. Systematic review and meta-analysis of the effect of probiotic supplementation on functional constipation in children[J]. Medicine, 2018, 97(39):e12174.
[7] VRIESMAN M H, KOPPEN I J N, CAMILLERI M, et al. Management of functional constipation in children and adults[J]. Nature Reviews Gastroenterology & Hepatology, 2020, 17(1):21-39.
[8] ARUMUGAM M, RAES J, PELLETIER E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473(7346):174-180.
[9] SIMRÉN M, BARBARA G, FLINT H J, et al. Intestinal microbiota in functional bowel disorders:a Rome foundation report[J]. Gut, 2013, 62(1):159-176.
[10] FENG X B, SU Y, JIANG J, et al. Changes in fecal and colonic mucosal microbiota of patients with refractory constipation after a subtotal colectomy[J]. The American Surgeon, 2015, 81(2):198-206.
[11] ZOPPI G, CINQUETTI M, LUCIANO A, et al. The intestinal ecosystem in chronic functional constipation[J]. Acta Paediatrica, 2010, 87(8):836-841.
[12] ZHU L, LIU W, ALKHOURI R, et al. Structural changes in the gut microbiome of constipated patients[J]. Physiological Genomics, 2014, 46(18):679-686.
[13] 李豪, 杨永志, 袁耀宗, 等. 双歧杆菌三联活菌制剂治疗功能性便秘临床疗效Meta分析[J]. 中国实用内科杂志, 2016, 36(8):724-728.
[14] PARTHASARATHY G, CHEN J, CHEN X, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation[J]. Gastroenterology, 2016, 150(2):367-379.
[15] 李宁, 田宏亮.菌群移植在肠道微生态相关疾病中的研究进展与思考[J]. 中华胃肠外科杂志, 2017, 20(10):1104-1108.
[16] 王宝西, 郭宏伟.益生菌在儿童功能性便秘的应用[J]. 中国实用儿科杂志, 2017, 32(2):28-31.
[17] 臧凯丽, 江岩, 孙勇, 等. 益生菌剂调整肠道疾病人群菌群结构丰度水平的研究[J]. 食品科学, 2018, 39(13):133-143.
[18] 葛晓龙, 丁超, 龚剑峰, 等. 菌群移植联合水溶性膳食纤维和益生菌治疗慢性便秘的近期疗效观察[J]. 中华胃肠外科杂志, 2016, 19(12):1355-1359.
[19] ISHIZUKA A, TOMIZUKA K, AOKI R, et al. Effects of administration of Bifidobacterium animalis subsp.lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans[J]. J Biosci Bioeng, 2012, 113(5):587-591.
[20] COCCORULLO P, STRISCIUGLIO C, MARTINELLI M, et al. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation:a double-blind, randomized, placebo-controlled study[J]. Journal of Pediatrics, 2010, 157(4):598-602.
[21] 刘娟, 李敏, 马艳.益生菌联合小麦纤维素颗粒治疗功能性便秘的疗效及安全性[J]. 医学临床研究, 2019, 36(6):1206-1208.
[22] 郑志昌, 陈映彤, 郭娟娟, 等. 益生元对早产儿、肥胖及老年群体肠道菌群调节机制的研究现状[J]. 食品科学, 2018, 39(1):297-304.
[23] CLOSA-MONASTEROLO R, FERRÉ N, CASTILLEJO-DEVILLASANTE G, et al. The use of inulin-type fructans improves stool consistency in constipated children.A randomised clinical trial:pilot study[J]. Int J Food Sci Nutr, 2017, 68(5):587-594.
[24] HEE H S, BAE H K, YOUNG K E, et al. Effect of dual-type oligosaccharides on constipation in loperamide-treated rats[J]. Nutr Res Pract, 2016, 10(6):583-589.
[25] WAITZBERG D L, PEREIRA C C A, LOGULLO L, et al. Microbiota benefits after inulin and partially hydrolized guar gum supplementation:a randomized clinical trial in constipated women[J]. Nutr Hosp, 2012, 27(1):123-129.
[26] LIU F, LI P, CHEN M, et al. Fructooligosaccharide (FOS) and galactooligosaccharide (GOS) increase bifidobacterium but reduce butyrate producing bacteria with adverse glycemic metabolism in healthy young population[J]. Sci Rep, 2017, 7(1):11789.
[27] 金庆崇, 陈悦, 宋娇.合生元制剂在功能性便秘治疗中的应用[J]. 实用药物与临床, 2018, 21(11):79-82.
[28] 黄林生, 严雪冰, 李豪, 等. 合生元对慢性功能性便秘患者肠道菌群的影响[J]. 中华临床营养杂志, 2018, 26(4):228-234.
[29] LIU Y, LIU B, LI D, et al. Improved gastric acid resistance and adhesive colonization of probiotics by mucoadhesive and intestinal targeted konjac glucomannan microspheres[J]. Advanced Functional Materials, 2020, 30(35):2001157.
[30] WAITZBERG D L, LOGULLO L C, BITTENCOURT A F, et al. Effect of synbiotic in constipated adult women-a randomized, double-blind, placebo-controlled study of clinical response[J]. Clin Nutr, 2013, 32(1):27-33.
[31] FORD A C, QUIGLEY E M M, LACY B E, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation:systematic review and Meta-analysis[J]. Am J Gastroenterol, 2014, 109(10):1547-1561.
[32] 杜三军, 高会斌, 李多, 等. 粪菌移植联合乳果糖对老年慢性功能性便秘的治疗效果[J]. 实用医学杂志, 2019, 35(17):2731-2736.
[33] LIU H, GONG F, WEI F, et al. Artificial simulation of salivary and gastrointestinal digestion, and fermentation by human fecal microbiota, of polysaccharides from Dendrobium aphyllum[J]. RSC Advances, 2018, 8(25):13954-13963.
[34] KAILA R B.Fecal microbiota transplantation:an effective treatment option for clostridium difficile infection[J]. Journal of the Electrochemical Society, 2015, 127(9):C357.
[35] KELLERMAYER R.Fecal microbiota transplantation:great potential with many challenges[J]. Transl Gastroenterol Hepatol, 2019, 4:40.
[36] 张发明.粪菌移植的概念、历史、现状和未来[J]. 中国内镜杂志, 2012, 18(9):930-934, 938.
[37] CAMMAROTA G, IANIRO G, TILG H, et al. European FMT Working Group.European consensus conference on fecal microbiota transplantation in clinical practice[J]. Gut, 2017, 66(4):569-580.
[38] SERRA J, POHL D, AZPIROZ F, et al. European society of neurogastroenterology and motility guidelines on functional constipation in adults[J]. Neurogastroenterol Motil, 2020, 32(2):e13762.
[39] BRANDT L J, ARONIADIS O C.An overview of fecal microbiota transplantation:techniques, indications, and outcomes[J]. Gastrointest Endosc, 2013, 78(2):240-249.
[40] 李宁, 田宏亮, 马春联, 等. 菌群移植治疗肠道疾病2010例疗效分析[J]. 中华胃肠外科杂志, 2019, 20(1):40-46.
[41] 田宏亮, 丁超, 马春联, 等. 粪菌胶囊治疗慢传输型便秘15例临床疗效分析[J]. 中国实用外科杂志, 2016, 36(4):430-432.
[42] 金铖钺, 胡莹, 金博.粪便微生物群移植在部分消化疾病治疗中的应用及安全性问题[J]. 世界华人消化杂志, 2020, 28(4):135-143. |
